Health Enlicitide Decanoate Meets Key Endpoints in Cholesterol Trial A new oral treatment for hypercholesterolemia, enlicitide decanoate, has successfully achieved all primary and key secondary endpoints in the pivotal CORALreef Lipids trial. Conducted... Editorial1 day ago